Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 CASI PharmaceuticalsTcr2 TherapeuticsCabaletta BioAutolus TherapeuticsJounce Therapeutics
SymbolNASDAQ:CASINASDAQ:TCRRNASDAQ:CABANASDAQ:AUTLNASDAQ:JNCE
Price Information
Current Price$2.62$11.22$7.90$13.05$5.76
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.81.61.51.42.0
Analysis Score3.53.53.53.53.3
Community Score2.52.52.82.42.7
Dividend Score0.00.00.00.00.0
Ownership Score3.02.01.01.02.0
Earnings & Valuation Score0.00.00.00.01.9
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$3.50$19.00$22.00$22.67$9.50
% Upside from Price Target33.59% upside69.34% upside178.48% upside73.69% upside64.93% upside
Trade Information
Market Cap$267.42 million$270.13 million$189.87 million$518.28 million$191.04 million
Beta0.951.78N/A2.092.37
Average Volume317,067110,411112,093150,625241,043
Sales & Book Value
Annual Revenue$4.13 millionN/AN/A$2.91 million$147.87 million
Price / Sales64.02N/AN/A180.051.33
CashflowN/AN/AN/AN/A$1.83 per share
Price / CashN/AN/AN/AN/A3.15
Book Value$0.76 per share$6.68 per share$5.76 per share$6.35 per share$5.25 per share
Price / Book3.45N/AN/A2.061.10
Profitability
Net Income$-46,030,000.00$-47,600,000.00$-16,940,000.00$-123,850,000.00$56.82 million
EPS($0.42)($4.62)($4.07)($2.88)$1.66
Trailing P/E RatioN/AN/AN/AN/A4.68
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A-9,870.67%46.11%
Return on Equity (ROE)-51.65%-32.20%N/A-45.59%28.10%
Return on Assets (ROA)-37.72%-30.77%N/A-38.88%21.33%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A0.08%0.11%
Current Ratio7.93%21.69%41.19%10.78%10.66%
Quick Ratio7.66%21.69%41.19%10.78%10.66%
Ownership Information
Institutional Ownership Percentage21.55%59.22%66.43%38.12%75.76%
Insider Ownership Percentage24.29%39.07%N/AN/A43.97%
Miscellaneous
Employees1244712N/A115
Shares Outstanding100.92 million24.08 million24.03 million40.15 million34.05 million
Next Earnings Date8/14/2020 (Estimated)8/13/2020 (Estimated)8/11/2020 (Estimated)N/A8/5/2020 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.